Alpha-cyclodextrin is a fascinating carbohydrate molecule

Today's cyclodextrin

Clinical studies suggest that αCD may help:
– Lower LDL cholesterol and triglycerides
– Support healthy weight management when combined with lifestyle changes
– Improve post-meal glucose control, contributing to metabolic health

Would you try it out in your supplement menu?

As research continues, we’re excited to see how cyclodextrins like αCD can be integrated into future nutritional and therapeutic solutions.

Alpha-cyclodextrin (αCD) is more than just a fascinating carbohydrate molecule – it’s gaining recognition as a supportive tool in weight and cholesterol management.

Thanks to its unique ring-shaped structure, αCD can bind dietary fats in the digestive tract, reducing their absorption.

capric acid, alpha-cyclodextrin

Cyclodextrin Masterclass VIII – Delivering small molecules

education, news,

Struggling with solubility, stability, or bioavailability issues in your formulation work? Curious about how cyclodextrins can help overcome these challenges?

In this free, online session, our experts will walk you through practical strategies for using cyclodextrins to improve the performance of small molecule drugs.

Whether you’re working in pharma, biotech, or academic research, you’ll come away with actionable insights and real-world examples.

Expect a fast-paced, engaging overview that covers formulation basics, common pitfalls, and advanced tricks that only seasoned CD scientists know.

This is your chance to get your questions answered live and see how CarboHyde’s innovative tools and knowledge can support your projects. Don’t miss it!

Register and Join us on Sept 4th at 2.00 pm (CEST)!

CarboHyde Poster Prize

news, education,


To be awarded at the 8th European Cyclodextrin Conference

CarboHyde is pleased to sponsor a Poster Prize recognizing the industrially most relevant research presented at the conference.

The award will be granted to a single poster presenter whose work demonstrates outstanding potential for industrial application, as selected by the attending members of CarboHyde.

Prize:
• Award certificate (diploma)
• Fully funded two-week research scholarship at CarboHyde in Budapest, including hands-on laboratory training and mentorship.

The scholarship is intended to support the continuation of the awardee’s research and to foster collaborative development with CarboHyde, with a view to translating academic findings into industrial solutions.

We look forward to engaging with talented researchers and supporting innovation in cyclodextrin science.

EuroCD 2025 CarboHyde

New paper in Carbohydrate Polymers

Today's cyclodextrin, news,

Here, Milo Malanga in collaboration with our long-time partners Szabolcs Béni & Bezhan Chankvetadze discuss the mechanisms of enantiomer binding and recognition with cyclodextrins by integrating capillary electrophoresis, nuclear magnetic resonance and quantum mechanics.

mariam shanidze, Nutsa Tsetskhladze, Antonio Salgado, Paola Peluso, Roberto Dallocchio, Gerhard Scriba

Understanding the mechanisms of enantiomer binding and recognition with cyclodextrins by integrating capillary electrophoresis, nuclear magnetic resonance and quantum mechanics

Julia, what was it like to do a secondment at CarboHyde?

news

“I most certainly loved learning something completely new every day!

I done a bit of chemistry in secondary school and then first year of uni and then I was essentially purely biology.

So I know this may seem like an obvious thing since we’re all in science but I really do love learning and getting to see how it works and actually see it happening infront of me was really cool.

The chemistry behind cyclodextrins and then seeing their applications in biology just go hand in hand, and I am one of those people that want to understand everything I’m doing to get the full picture.

It can give me a better perspective on what I’m doing and I can start to see things from another angle as well and question thing differently.”

Julia Krakowiak spent a few weeks in our labs supported by the Bicyclos HEurope grant. (the handsome fellow is our CSO, Milo Malanga)

Hope to see you again soon!

Milo Malanga Julia Krakowiak CarboHyde

Big News from CarboHyde!

news,

We’re thrilled to announce our first-ever exhibition at CPHI — the world’s leading pharma event!

This marks a major milestone for CarboHyde as we step onto the global stage to showcase our innovative cyclodextrin technology.

📍 Where: CPHI Worldwide
📅 When: Oct 28-30
📌 Booth: 4S176

Our team is excited to connect with industry leaders, explore new partnerships, and share how CarboHyde is drug delivery.

If you’re attending, come say hello — we’d love to meet you!

CPHI Carbohyde 2025

Another milestone in our collaboration with Cyclarity Therapeutics

Egyéb kategória

Sequestering toxic 7-keto-cholesterol, our arch enemy from our bodies for good.

Our CSO, Milo Malanga PhD is among the inventors on this freshly published patent detailing this groundbreaking cyclodextrin dimer technology that has a chance to reverse atherosclerosis and change the life of hundreds of millions.

A true longevity pioneer crew, super happy to work with you Matthew “Oki” O’Connor, Michael Kope, Christina Tom and Amelia Anderson.

Read the patent here: WIPO – Search International and National Patent Collections

cyclarity, patent, CarboHyde

CarboHyde Poster Prize

news, ,

To be awarded at the 8th European Cyclodextrin Conference

CarboHyde is pleased to sponsor a Poster Prize recognizing the industrially most relevant research presented at the conference.

The award will be granted to a single poster presenter whose work demonstrates outstanding potential for industrial application, as selected by the attending members of CarboHyde.

Prize:
• Award certificate (diploma)
• Fully funded two-week research scholarship at CarboHyde in Budapest, including hands-on laboratory training and mentorship.

The scholarship is intended to support the continuation of the awardee’s research and to foster collaborative development with CarboHyde, with a view to translating academic findings into industrial solutions.

We look forward to engaging with talented researchers and supporting innovation in cyclodextrin science.

EuroCD

CarboHyde at PODD in Boston

news,

Who is presenting at PODD?

We are!

CarboHyde is super excited to sponsor PODD and delegate Tamas Kiss, PhD to deliver az oral presentation in the a Soapbox Session soon in Boston.

The event will have the ever prestigious keynotes featuring Novo Nordisk, Regeneron, AstraZeneca and Roche, along with the annual keynote from Robert Langer, who is similarly interested in cyclodextrin science.

FYI, if you got tempted to join, you get 10% Off with Code CARBOH10.

PODD: Partnership Opportunities in Drug Delivery Community News

PODD, Kiss Tamás